News
The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...
50m
Stocktwits on MSNThis Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees OpportunityWells Fargo on Thursday raised its price target on Sarepta Therapeutics, Inc. (SRPT) to $50 from $48 after the company’s ...
SRPT rallies after Q2 earnings and revenue beat expectations as Elevidys deliveries resume following FDA clearance.
Sarepta did not hold an investor call for its second-quarter earnings report or provide an updated full-year revenue outlook.
One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...
After a second Elevidys patient death from acute liver failure, Sarepta in July launched a major restructuring that involves ...
Shares of Sarepta Therapeutics ( NASDAQ: SRPT) rose on Wednesday after the market as it reported second quarter revenue and ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
Sarepta Therapeutics hired a Trump-connected lobbying firm after the death of a teenage boy treated with its Duchenne ...
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
In his first town hall since voting in favor of Donald Trump’s “big, beautiful bill,” Nebraska Representative Mike Flood had ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results